Lexaria Bioscience Corp (LEXX)

[TonyX]

NOT $5mm per year
"In order to retain ongoing exclusivity, the negotiated minimum quarterly payments ("Payments") to Lexaria begin September 1, 2022 and, during the first five years of the Agreement, amount to US$4,527,500."

It DOES NOT say this amount PER YEAR...if it was per year, it would be explicit. That's the total. Also, that is only to maintain EXCLUSIVITY. They do not need to maintain exclusivity at the moment as Lexaria has no other Japan deals ad hasn't mentioned any. So, it's feasable that they never make any of these payments unless a major competitor wants to use the tech.

Also, who cares what this company's PARENT sales are. This is a red herring to make people think this deal has large potential. At the moment, this company's revenue do not come from products that LEXX's tech will help, so they are creating new products (maybe).

The article doesn't even mention what products might be created.
This partnership at the moment, is fairly meaningless and basically says nothing more than "Japanese cosmetics company might start using our technology, and if they do, we will get royalty payments, but we aren't saying what they are. BUT, they would have to pay to keep us from licensing our tech to other Japanse companies, but we haven't started doing that yet either."